基本信息
views: 169
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Holsinger is Professor and Chief of Head and Neck Surgery at Stanford University.
His research focuses on surgical innovation and clinical trials through NCI-funded cooperative groups. He serves as surgical principal investigator for RTOG920 and coordinated surgeon-credentialing for ECOG 3311, a prospective clinical trial to study robotic head and neck surgery. He leads an investigative device exemption trial to evaluate the safety and efficacy of anext-generation flexible robotic surgical system.
In 2014, he began a prospective clinical trial to evaluate multispectral imaging of patients with oropharyngeal cancer, in an effort to discern tumor from tumor. Currently, he leads a study to evaluate hyper-spectral imaging to improve surgical vision.
From 2003-2013, Dr. Holsinger worked at the Department of Head and Neck Surgery at the University of Texas M.D. Anderson Cancer Center where he founded and led the Program in Minimally Invasive and Endoscopic Head and Neck Surgery and co-directed the program in Minimally Invasive Technology in Oncologic Surgery.
Dr. Holsinger’s surgical practice focuses on the surgical management of benign and malignant diseases of the thyroid, as well as head and neck cancer. His areas of research interest include endoscopic head and neck surgery, including transoral robotic surgery and transoral laser microsurgery, as well as time-honoured approaches of conservation laryngeal surgery and supracricoid partial laryngectomy.
At the Cancer Center, Dr. Holsinger has led an effort to improve the quality of multidisciplinary tumor boards in H&N, but also across the Cancer Center, beginning with the founding of the H&N Multidisciplinary Cancer Care Clinical Program in 2014.
Dr. Holsinger has authored or co-authored numerous articles and abstracts, which have appeared in publications such as the New England Journal of Medicine, Journal of the American College of Surgeons, the Journal of Clinical Oncology, Clinical Cancer Research, Head & Neck, Laryngoscope, and the Archives of Otolaryngology—Head and Neck Surgery.
Board-certified by the American Board of Otolaryngology, Dr. Holsinger is a member of numerous societies including the American College of Surgeons, the American Society of Clinical Oncology, and the American Head and Neck Society.
His research focuses on surgical innovation and clinical trials through NCI-funded cooperative groups. He serves as surgical principal investigator for RTOG920 and coordinated surgeon-credentialing for ECOG 3311, a prospective clinical trial to study robotic head and neck surgery. He leads an investigative device exemption trial to evaluate the safety and efficacy of anext-generation flexible robotic surgical system.
In 2014, he began a prospective clinical trial to evaluate multispectral imaging of patients with oropharyngeal cancer, in an effort to discern tumor from tumor. Currently, he leads a study to evaluate hyper-spectral imaging to improve surgical vision.
From 2003-2013, Dr. Holsinger worked at the Department of Head and Neck Surgery at the University of Texas M.D. Anderson Cancer Center where he founded and led the Program in Minimally Invasive and Endoscopic Head and Neck Surgery and co-directed the program in Minimally Invasive Technology in Oncologic Surgery.
Dr. Holsinger’s surgical practice focuses on the surgical management of benign and malignant diseases of the thyroid, as well as head and neck cancer. His areas of research interest include endoscopic head and neck surgery, including transoral robotic surgery and transoral laser microsurgery, as well as time-honoured approaches of conservation laryngeal surgery and supracricoid partial laryngectomy.
At the Cancer Center, Dr. Holsinger has led an effort to improve the quality of multidisciplinary tumor boards in H&N, but also across the Cancer Center, beginning with the founding of the H&N Multidisciplinary Cancer Care Clinical Program in 2014.
Dr. Holsinger has authored or co-authored numerous articles and abstracts, which have appeared in publications such as the New England Journal of Medicine, Journal of the American College of Surgeons, the Journal of Clinical Oncology, Clinical Cancer Research, Head & Neck, Laryngoscope, and the Archives of Otolaryngology—Head and Neck Surgery.
Board-certified by the American Board of Otolaryngology, Dr. Holsinger is a member of numerous societies including the American College of Surgeons, the American Society of Clinical Oncology, and the American Head and Neck Society.
Research Interests
Papers共 297 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Scott Roof,Glenn J. Hanna,Eleni M. Rettig,David M. Routman,Floyd Christopher Holsinger,Noah Kalman,Aarti K. Bhatia,Mihir R. Patel, Jamie Jabalee,Sue S. Yom, Sujith Baliga,Adam Raben,
Journal of Clinical Oncologyno. 16_suppl (2024)
CoRR (2024)
Cited0Views0EIBibtex
0
0
The Laryngoscope (2024)
Otolaryngologic Clinics of North America (2024)
Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-facialeno. 2 (2024): 111
Alexis Miller, Vickie Wang, Victor Jegede,Fabian Necker,Joseph Curry,Fred M. Baik, Avanti Verma,F. Christopher Holsinger,Madalina Tuluc, Mobeen Rahman,James S. Lewis,Eben Rosenthal,
Head & neck (2024)
European annals of otorhinolaryngology, head and neck diseasesno. 1 (2024): 41-45
The Laryngoscope (2024)
JAMA otolaryngology-- head & neck surgeryno. 2 (2024): 165-171
Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-facialeno. 1 (2024): 37-41
Load More
Author Statistics
#Papers: 290
#Citation: 8935
H-Index: 47
G-Index: 86
Sociability: 7
Diversity: 3
Activity: 49
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn